Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review - Mantovani, A; Byrne, C D; Targher, G
Lancet Gastroenterol Hepatol 2022:S2468-1253(21)00261-2